Distribution of blaTEM, blaSHV, blaCTX-M genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran

Microbial Drug Resistance

Volumn 16, Issue 1, 2010, Pages 49-53

  Feizabadi, Mohammad Mehdi ^a   Delfani, Somayeh ^a   Raji, Nafiseh ^a   Majnooni, Araz ^a   Aligholi, Marzieh ^a   Shahcheraghi, Fereshteh ^b   Parvin, Mahmood ^c   Yadegarinia, Davud ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PLASMID DNA;

AGAR DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLA CTX M I GENE; BLA CTX M III; BLA SHV GENE; BLA TEM GENE; GENE AMPLIFICATION; IRAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANTI-INFECTIVE AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; DNA, BACTERIAL; GENES, BACTERIAL; HOSPITALS, TEACHING; HUMANS; IRAN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

KLEBSIELLA PNEUMONIAE;

EID: 77949573993     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2009.0096     Document Type: Article

References (30)

1. Al-Agamy, M.H., A.M. Shib, and A.F. Tawfik. 2009. Prevalence and molecular characterization of extendedspectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann. Saudi Med. 29:253-257.
2. Al-Zarouni, M., A. Senok, F. Rashid, S.M. Al-Jesmi, and D. Panigrahi. 2008. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med. Princ. Pract. 17:32-36.
3. Arpin, C., L. Coulange, V. Dubois, C. André , I. Fischer, S. Fourmaux, et al. 2007. Extended-spectrum b-lactamases producing Enterobacteriaceae strains in various types of private health care centers. Antimicrob. Agents Chemother. 51:3440-3444.
4. Babini, G.S., and D.M. Livermore. 2000. Are SHV betalactamases universal in Klebsiella pneumoniae? Antimicrob. Agents Chemother. 44:2230.
5. Bonnet, R. 2004. Growing group of extended-spectrum blactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
6. Carrer, A., L. Poirel, H. Eraksoy, A.A. Cagatay, S. Badur, and P. Nordmann. 2008. Spread of OXA-48-positive carbapenem- resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob. Agents. Chemother. 52:2950-2954.
7. [CLSI] Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved Standard M2=A7. CLSI, Wayne, 2002.
8. Coque, T.M., F. Buquero, and R. Canton. 2008. Increasing prevalence of ESBL- producing Enterobacteriaceae in Europe. Euro Surveill. 13:pii19044.
9. Damjanova IToth, A., J. Paszti, G. Hajbel-Vekony, M. Jakab, J. Berta, H. Milch, et al. 2008. Expansion and countrywide dissemination of ST11, ST15, and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamases producing Klebsiella pneumoniae epidemic clones in Hungary in 2005-the new MRSAs? J. Antimicrob. Chemother. 62:978-985.
10. Feizabadi, M.M., G. Etemadi, D. Yadegarinia, M. Rahmati, S. Shabanpoor, and S. Bokaei. 2006. Antibiotic-resistance patterns and frequency of extended-spectrum betalactamase- producing isolates of Klebsiella pneumoniae in Tehran. Med. Sci. Monit. 12:362-365.
11. Gupta, A., K. Ampofo, D. Rubenstein, and L. Saiman. 2003. Extended-spectrum b-lactamase-producing Klebsiella pneumoniae infection: review of the literature. J. Perinatol. 23:439-443.
12. Harada, S., Y. Ishii, and K. Yamaguchi. 2008. Extendedspectrum b-lactamases: implications for the clinical laboratory and therapy. Korean J. Lab Med. 28:401-412.
13. Hernandez, J.R., L. Martinez-Martinez, R. Canton, T.M. Coque, and A. Pascual. 2005. Spanish Group for Nosocomial Infections. Nationwide study of Esherichia coli and Klebsiella pneumoniae producing extended-spectrum b-lactamases in Spain. Antimicrob. Agents Chemother. 49:2122-2125
14. Jacoby, G.A., and A.A. Medeiros. 1991. More extendedspectrum b-lactamases. Antimicrob. Agents Chemother. 35: 1697-1704.
15. Korten, V., S. Ulusoy, P. Zarakolu, and B. Mete. 2007. Turkish MISTIC Study Group. Antibiotic resistance surveillance over 4-year period (200-20003) in Turkey: results of the MISTIC program. Diagn. Microbiol. Infect. Dis. 59:453-457.
16. Livermore, D.M., R. Canton, M. Gniadkowski, P. Nordmann, G.M. Rossollini, G. Arlet, et al. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-167.
17. Lytsy, B., L. Sandegren, E. Tano, E. Torell, D.I. Andersson, and A. Melhus. 2008. The first major extended-spectrum blactamases outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 116:302-308.
18. Machado, E., T.M. Coque, R. Cantó n, A. Novais, J.C. Sousa, F. Baquero, et al. 2007. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J. Antimicrob. Chemother. 60:1370-1374.
19. Markovska, R., I. Schneider, E. Keuleyan, M. Sredkova, D. Ivanova, B. Markov, et al. 2008. Extended-spectrum betalactamases producing Enterobacteriaceae in Bulgarian hospitals. Microb. Drug Resist. 14:119-128.
20. Monstein, H.J., A. Ostholm-Balkhed, N.V. Nilsson, M. Nilsson, K. Dornbusch, and L.E. Nilsson. 2007. Multiplex PCR amplification assay for rapid detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae. APMIS 115:1400-1408.
21. Moubareck, C., Z. Daoud, N.I. Hakimé , M. Hamzé, N. Mangeney, H. Matta, et al. 2005. Countrywide spread of community- and hospital-acquired extended-spectrum betalactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. J. Clin. Microbiol. 43:3309-3313.
22. Nyberg, S.D., M. Osterblad, A.J. Hakanen, P. Huovinen, and J. Jalava. 2007. The Finish Study Group for antimicrobial resistance, detection and molecular genetics of extendedspectrum b-lactamases among cefuroxime-resistant Esherichia coli and Klebsiella spp. isolates from Finland, 2002-2004. Scand. J. Infect. Dis. 39:417-424.
23. Paterson, D.L., and R.A. Bonomo. 2005. Extended-spectrum b-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
24. Pitout, J.D.D., A. Hossain, and N.D. Hanson. 2004. Phenotypic and molecular detection of CTX-M-lactamases produced by Escherichia coli and Klebsiella spp. J. Clin. Microbiol. 42:5715-5721.
25. Rahal, J.J., C. Urban, D. Horn, K. Freeman, S. Segal- Maurer, J. Maurer, et al. 1998. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280:1233-1237.
26. Rossolini, G.M., M.M. D'Andrea, and C. Mugnaioli. 2008. The spread of CTX-M-type extended-spectrum b-lactamases. Clin. Microbiol. Infect. 14(S):S33-S41.
27. Shah, A.A., F. Hasan, S. Ahmad, and A. Ahmad. 2004. Prevalence of extended-spectrum beta-lactamase in nosocomial and outpatients (ambulatory). Pak. J. Med. Sci. 19:187-191.
28. Woodford, N., and A.P. Johnson. 1998. Molecular Bacteriology and Clinical Application. Humana Press, Totowa, New Jersey, pp. 17-33.
29. Yates, C.M., D.J. Brown, G.F. Edwards, and S.G. Amyes. 2004. Detection of TEM-52 in Salmonella enteric serovar Enteritidis in Scotland. J. Antimicrob. Chemother. 53:407-408.
30. Yumuk, Z., G. Afacan, M.H. Nicolas-Chanoine, A. Sotto, and J.P. Lavigne. 2008. Turkey: a further country concerned by community-acquired of Esherichia coli clone 025- ST131producing CTX-M-15. J. Antimicrob. Chemother. 62: 284-288